Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

21 Apr 2015 16:22

RNS Number : 9044K
Phorm Corporation Limited
21 April 2015

21 April 2015

Phorm Corporation Limited

("Phorm" or the "Company")

Operational Update

Phorm (AIM: PHRM), a leading internet personalisation technology company, is pleased to announce an unaudited operational update.

Highlights:

Commercial operations commenced in the US

Strong growth in sales and sales pipeline in Russia

Potential partnership discussions progressing in China

Significant performance improvements following the release of new algorithms

Second phase of major cost reduction programme initiated

On 16 January 2015, Phorm announced that it was continuing to make very good progress in respect of the group's key performance indicators. The Company is pleased to announce continued progress with the recent commencement of commercial operations in the United States of America ("US").

The US is the world's largest online advertising market; according to PricewaterhouseCoopers, in 2015, it will be worth approximately US$52bn. Accordingly, the Company believes the commercial prospects for its market leading technology in the US are most promising and has been encouraged by the rapid growth in unique users achieved within the first month of commercial operations. In addition, in terms of inventory, the Company now has access to over 9bn advertising requests per day in the US.

Phorm has also experienced strong revenue growth in Russia, despite the challenging macro economic conditions prevalent in this market. The unaudited gross revenue derived from Russia in March 2015 was in excess of RUB8m and the Company expects this growth to accelerate significantly based on its current sales pipeline.

Russian Operations Gross Revenue

Date

Gross Revenue (RUB)

Aug 2014

202,418

Sep 2014

1,301,292

Oct 2014

2,105,801

Nov 2014

2,045,712

Dec 2014

5,633,268

Jan 2015

3,231,175

Feb 2015

4,493,894

Mar 2015

8,016,510

In China, the Company has encountered a number of operational challenges and has therefore concluded that the most effective and expedient means to achieve its objectives in this particular market is through the establishment of a potential partnership with a large local player. Several conversations are currently ongoing and the Company will update the market in due course as such discussions progress.

On 16 January 2015, the Company also announced that it had launched its machine learning algorithm. Through its relationships with Internet Service Providers ("ISPs"), Phorm has access to substantial amounts of data, which it is able to analyse anonymously and in real time. The machine learning algorithms have already provided a significant increase in both the efficiency and performance of Phorm's technology. The efficiency improvements arise from the way in which the algorithm informs the prices of the bids on real time bidding platforms, where there have been increases of approximately 300 per cent. The performance improvements stem from the manner in which the algorithm can anonymously spot user buying patterns. The performance improvements achieved have been as high as 350 per cent.

By improving both performance and efficiency, whilst reducing the amount of manual input required, the machine learning algorithm has also opened up the possibility of concluding potential licensing agreements with third parties in order to further accelerate the commercialisation of the platform. A number of these discussions are ongoing and the Company currently anticipates being able to announce its first licencing deal in the coming months.

The first phase of the Company's previously announced cost reduction exercise has also been successfully completed and the Company is now implementing a second phase which, in part due to the operational efficiencies created by the abovementioned machine learning algorithm, should achieve further annualised cost savings of approximately US$400-600k.

The combination of our commercial launch in the US, together with strong revenue growth in Russia, ongoing partnership discussions in China, enhanced performance and a reducing cost base means that the Company continues to be optimistic about its commercial outlook for the remainder of 2015 and beyond.

-Ends-

For further information please contact:

Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 20 3397 6001

UK Investors

Mirabaud Securities LLP (Broker) +44 20 7321 2508

Jason Woollard

Peter Krens

Strand Hanson Limited (Nominated Adviser) +44 20 7409 3494

James Harris

Matthew Chandler

James Dance

US Investors

Lippert/Heilshorn and Associates (Investor Relations) +1 212 838 3777

John Heilshorn

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

Phorm, under a predecessor holding company, was admitted to trading on the AIM market of the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEFLFLEZFFBBX
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.